Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Repare Therapeutics Inc (RPTX)

Repare Therapeutics Inc (RPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Repare Therapeutics Inc 7171 Frederick-Banting Building 2 Suite 270 St-Laurent A8 H4S 1Z9 CAN

www.reparerx.com P: 857-412-7018

Description:

Repare Therapeutics Inc. is an oncology company. It utilizes genome-wide, CRISPR-enabled SNIPRx(R) platform to discover and develop targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company's product pipeline includes RP-3500, which is in clinical stage. Repare Therapeutics Inc. is based in St-Laurent, Canada.

Key Statistics

Overview:

Market Capitalization, $K 139,644
Enterprise Value, $K 28,374
Shares Outstanding, K 42,445
Annual Sales, $ 51,130 K
Annual Net Income, $ -93,800 K
Last Quarter Sales, $ 1,070 K
Last Quarter Net Income, $ -34,770 K
EBIT, $ -95,790 K
EBITDA, $ -101,300 K
60-Month Beta 0.71
% of Insider Shareholders 21.60%
% of Institutional Shareholders 85.09%
Float, K 33,277
% Float 78.40%
Short Volume Ratio 0.46

Growth:

1-Year Return -70.36%
3-Year Return -87.98%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.82 on 08/06/24
Next Earnings Date 08/14/24
Earnings Per Share ttm -1.64
EPS Growth vs. Prev Qtr -373.33%
EPS Growth vs. Prev Year -192.86%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RPTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -31.11%
Return-on-Assets % -26.39%
Profit Margin % -183.45%
Debt/Equity 0.00
Price/Sales 2.76
Price/Cash Flow N/A
Price/Book 0.74
Book Value/Share 4.80
Interest Coverage -2.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar